Dopamine- and cAMP-regulated phosphoprotein of 32-kDa (DARPP-32)-dependent activation of extracellular signal-regulated kinase (ERK) and mammalian target of rapamycin complex 1 (mTORC1) signaling in experimental parkinsonism

Journal of Biological Chemistry

Volumn 287, Issue 33, 2012, Pages 27806-27812

  Santini, Emanuela ^a   Feyder, Michael ^a   Gangarossa, Giuseppe ^a   Bateup, Helen S ^b   Greengard, Paul ^b   Fisone, Gilberto ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEX 1; EXTRACELLULAR SIGNAL-REGULATED KINASE; EXTRACELLULAR SIGNAL-REGULATED PROTEIN KINASE; HYPERPHOSPHORYLATION; MAMMALIAN TARGET; PHOSPHORYLATION SITES; PROTEIN KINASE; SIGNALING CASCADES;

AMINES; ANTIBIOTICS; ENZYMES; NEUROPHYSIOLOGY; PHOSPHORYLATION; PROTEINS; SIGNALING;

CHEMICAL ACTIVATION;

BENSERAZIDE; CYCLIC AMP DEPENDENT PROTEIN KINASE; DOPAMINE 1 RECEPTOR; LEVODOPA; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHOPROTEIN DARPP 32;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DOSE COMPARISON; DYSKINESIA; ENZYME ACTIVATION; GENE DELETION; GENE MUTATION; MEDIUM SPINY NERVE CELL; MOUSE; NERVE CELL; NONHUMAN; PARKINSONISM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

ANIMALS; ANTIPARKINSON AGENTS; CYCLIC AMP; DOPAMINE; DOPAMINE AND CAMP-REGULATED PHOSPHOPROTEIN 32; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; LEVODOPA; MAP KINASE SIGNALING SYSTEM; MICE; MICE, TRANSGENIC; NERVE TISSUE PROTEINS; NEURONS; PARKINSONIAN DISORDERS; PROTEINS;

EID: 84865016327     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.388413     Document Type: Article

References (36)

1. Kish, S. J., Shannak, K., and Hornykiewicz, O. (1988) Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson disease. Pathophysiologic and clinical implications. N. Engl. J. Med. 318, 876-880
2. Marshall, J. F., and Ungerstedt, U. (1977) Supersensitivity to apomorphine following destruction of the ascending dopamine neurons. Quantification using the rotational model. Eur. J. Pharmacol. 41, 361-367
3. Gerfen, C. R., Engber, T. M., Mahan, L. C., Susel, Z., Chase, T. N., Monsma, F. J., Jr., and Sibley, D. R. (1990) D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 250, 1429-1432
4. Guigoni, C., Aubert, I., Li, Q., Gurevich, V. V., Benovic, J. L., Ferry, S., Mach, U., Stark, H., Leriche, L., Håkansson, K., Bioulac, B. H., Gross, C. E., Sokoloff, P., Fisone, G., Gurevich, E. V., Bloch, B., and Bezard, E. (2005) Pathogenesis of levodopa-induced dyskinesia. Focus on D1 and D3 dopamine receptors. Parkinsonism Relat. Disord. 11, S25-S29
5. Santini, E., Valjent, E., and Fisone, G. (2008) Parkinson disease. Levodopa-induced dyskinesia and signal transduction. FEBS J. 275, 1392-1399
6. Picconi, B., Centonze, D., Håkansson, K., Bernardi, G., Greengard, P., Fisone, G., Cenci, M. A., and Calabresi, P. (2003) Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia. Nat. Neurosci. 6, 501-506
7. Santini, E., Valjent, E., Usiello, A., Carta, M., Borgkvist, A., Girault, J. A., Hervé, D., Greengard, P., and Fisone, G. (2007) Critical involvement of cAMP/DARPP-32 and extracellular signal-regulated protein kinase signaling in L-DOPA-induced dyskinesia. J. Neurosci. 27, 6995-7005
8. Greengard, P. (2001) The neurobiology of slow synaptic transmission. Science 294, 1024-1030
9. Bateup, H. S., Santini, E., Shen, W., Birnbaum, S., Valjent, E., Surmeier, D. J., Fisone, G., Nestler, E. J., and Greengard, P. (2010) Distinct subclasses of medium spiny neurons differentially regulate striatal motor behaviors. Proc. Natl. Acad. Sci. U.S.A. 107, 14845-14850
10. Gerfen, C. R., Paletzki, R., and Worley, P. (2008) Differences between dorsal and ventral striatum in Drd1a dopamine receptor coupling of dopamine- and cAMP-regulated phosphoprotein-32 to activation of extracellular signal-regulated kinase. J. Neurosci. 28, 7113-7120
11. Pavón, N., Martín, A. B., Mendialdua, A., and Moratalla, R. (2006) ERK phosphorylation and FosB expression are associated with L-DOPA-induced dyskinesia in hemiparkinsonian mice. Biol. Psychiatry 59, 64-74
12. Westin, J. E., Vercammen, L., Strome, E. M., Konradi, C., and Cenci, M. A. (2007) Spatiotemporal pattern of striatal ERK1/2 phosphorylation in a rat model of L-DOPA-induced dyskinesia and the role of dopamine D1 receptors. Biol. Psychiatry 62, 800-810
13. Santini, E., Heiman, M., Greengard, P., Valjent, E., and Fisone, G. (2009) Inhibition of mTOR signaling in Parkinson disease prevents L-DOPA-induced dyskinesia. Sci. Signal. 2, ra36
14. Costa-Mattioli, M., Sossin, W. S., Klann, E., and Sonenberg, N. (2009) Translational control of long lasting synaptic plasticity and memory. Neuron 61, 10-26
15. Thomas, G. M., and Huganir, R. L. (2004) MAPK cascade signaling and synaptic plasticity. Nat. Rev. Neurosci. 5, 173-183
16. Santini, E., Sgambato-Faure, V., Li, Q., Savasta, M., Dovero, S., Fisone, G., and Bezard, E. (2010) Distinct changes in cAMP and extracellular signal-regulated protein kinase signalling in L-DOPA-induced dyskinesia. PLoS One 5, e12322
17. Schuster, S., Nadjar, A., Guo, J. T., Li, Q., Ittrich, C., Hengerer, B., and Bezard, E. (2008) The 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor lovastatin reduces severity of L-DOPA-induced abnormal involuntary movements in experimental Parkinson disease. J. Neurosci. 28, 4311-4316
18. Valjent, E., Corvol, J. C., Pages, C., Besson, M. J., Maldonado, R., and Caboche, J. (2000) Involvement of the extracellular signal-regulated kinase cascade for cocaine-rewarding properties. J. Neurosci. 20, 8701-8709
19. Bateup, H. S., Svenningsson, P., Kuroiwa, M., Gong, S., Nishi, A., Heintz, N., and Greengard, P. (2008) Cell type-specific regulation of DARPP-32 phosphorylation by psychostimulant and antipsychotic drugs. Nat. Neurosci. 11, 932-939
20. Svenningsson, P., Tzavara, E. T., Carruthers, R., Rachleff, I., Wattler, S., Nehls, M., McKinzie, D. L., Fienberg, A. A., Nomikos, G. G., and Greengard, P. (2003) Diverse psychotomimetics act through a common signaling pathway. Science 302, 1412-1415
21. Franklin, K. B. J., and Paxinos, G. (2008) The Mouse Brain in Stereotaxic Coordinates, 3rd Ed., Academic Press, San Diego
22. Lundblad, M., Picconi, B., Lindgren, H., and Cenci, M. A. (2004) A model of L-DOPA-induced dyskinesia in 6-hydroxydopamine lesioned mice. Relation to motor and cellular parameters of nigrostriatal function. Neurobiol. Dis. 16, 110-123
23. Towbin, H., Staehelin, T., and Gordon, J. (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets. Procedure and some applications. Proc. Natl. Acad. Sci. U.S.A. 76, 4350-4354
24. Snyder, G. L., Girault, J. A., Chen, J. Y., Czernik, A. J., Kebabian, J. W., Nathanson, J. A., and Greengard, P. (1992) Phosphorylation of DARPP-32 and protein phosphatase inhibitor-1 in rat choroid plexus. Regulation by factors other than dopamine. J. Neurosci. 12, 3071-3083
25. Hemmings, H. C., Jr., and Greengard, P. (1986) DARPP-32, a dopamine- and adenosine 3′:5′-monophosphate-regulated phosphoprotein. Regional, tissue, and phylogenetic distribution. J. Neurosci. 6, 1469-1481
26. Darmopil, S., Martín, A. B., De Diego, I. R., Ares, S., and Moratalla, R. (2009) Genetic inactivation of dopamine D1 but not D2 receptors inhibits L-DOPA-induced dyskinesia and histone activation. Biol. Psychiatry 66, 603-613
27. Santini, E., Alcacer, C., Cacciatore, S., Heiman, M., Hervé, D., Greengard, P., Girault, J. A., Valjent, E., and Fisone, G. (2009) L-DOPA activates ERK signaling and phosphorylates histone H3 in the striatonigral medium spiny neurons of hemiparkinsonian mice. J. Neurochem. 108, 621-633
28. Gerfen, C. R., Miyachi, S., Paletzki, R., and Brown, P. (2002) D1 dopamine receptor supersensitivity in the dopamine-depleted striatum results from a switch in the regulation of ERK1/2/MAP kinase. J. Neurosci. 22, 5042-5054
29. Brami-Cherrier, K., Valjent, E., Hervé, D., Darragh, J., Corvol, J. C., Pages, C., Arthur, S. J., Simon, A. J., Girault, J. A., and Caboche, J. (2005) Parsing molecular and behavioral effects of cocaine in mitogen- and stress-activated protein kinase-1-deficient mice. J. Neurosci. 25, 11444-11454
30. Ruvinsky, I., and Meyuhas, O. (2006) Ribosomal protein S6 phosphorylation: from protein synthesis to cell size. Trends Biochem. Sci. 31, 342-348
31. Valjent, E., Pascoli, V., Svenningsson, P., Paul, S., Enslen, H., Corvol, J. C., Stipanovich, A., Caboche, J., Lombroso, P. J., Nairn, A. C., Greengard, P., Hervé, D., and Girault, J. A. (2005) Regulation of a protein phosphatase cascade allows convergent dopamine and glutamate signals to activate ERK in the striatum. Proc. Natl. Acad. Sci. U.S.A. 102, 491-496
32. Hemmings, H. C., Jr., Greengard, P., Tung, H. Y., and Cohen, P. (1984) DARPP-32, a dopamine-regulated neuronal phosphoprotein, is a potent inhibitor of protein phosphatase-1. Nature 310, 503-505
33. Lebel, M., Chagniel, L., Bureau, G., and Cyr, M. (2010) Striatal inhibition of PKA prevents levodopa-induced behavioral and molecular changes in the hemiparkinsonian rat. Neurobiol. Dis. 38, 59-67
34. Alcacer, C., Santini, E., Valjent, E., Gaven, F., Girault, J. A., and Hervé, D. (2012) Gα(olf) mutation allows parsing the role of cAMP-dependent and extracellular signal-regulated kinase-dependent signaling in L-3,4-dihy-droxyphenylalanine-induced dyskinesia. J. Neurosci. 32, 5900-5910
35. Ma, L., Chen, Z., Erdjument-Bromage, H., Tempst, P., and Pandolfi, P. P. (2005) Phosphorylation and functional inactivation of TSC2 by ERK implications for tuberous sclerosis and cancer pathogenesis. Cell 121, 179-193
36. Roux, P. P., Ballif, B. A., Anjum, R., Gygi, S. P., and Blenis, J. (2004) Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase. Proc. Natl. Acad. Sci. U.S.A. 101, 13489-13494